scholarly article | Q13442814 |
P50 | author | Changlin Zhang | Q97883944 |
Yuanqi Zhao | Q59683732 | ||
P2093 | author name string | Yifan Sun | |
Lingling Liu | |||
Hui Mao | |||
Shaoqin Lin | |||
Haoxuan Chen | |||
Jiaying Lan | |||
Yingdi Liao | |||
P2860 | cites work | An automated method for finding molecular complexes in large protein interaction networks | Q21284295 |
Gene ontology: tool for the unification of biology | Q23781406 | ||
Global brain inflammation in stroke | Q91805720 | ||
Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network | Q91811051 | ||
Neuroprotective Effects of Musk of Muskrat on Transient Focal Cerebral Ischemia in Rats | Q92155876 | ||
Systems Pharmacology for Investigation of the Mechanisms of Action of Traditional Chinese Medicine in Drug Discovery | Q92403114 | ||
Stroke in China: advances and challenges in epidemiology, prevention, and management | Q92409091 | ||
Gene polymorphisms and circulating levels of the TNF-alpha are associated with ischemic stroke: A meta-analysis based on 19,873 individuals | Q92903869 | ||
Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 | Q93084985 | ||
Akt activation improves microregional oxygen supply/consumption balance after cerebral ischemia-reperfusion. | Q47839332 | ||
Muscone exerts neuroprotection in an experimental model of stroke via inhibition of the fas pathway. | Q48377076 | ||
Knockdown of Nrf2 inhibits angiogenesis by down-regulating VEGF expression through PI3K/Akt signaling pathway in cerebral microvascular endothelial cells under hypoxic conditions | Q48522321 | ||
AKT-related autophagy contributes to the neuroprotective efficacy of hydroxysafflor yellow A against ischemic stroke in rats | Q48788009 | ||
Protection against cerebral infarction by Withaferin A involves inhibition of neuronal apoptosis, activation of PI3K/Akt signaling pathway, and reduced intimal hyperplasia via inhibition of VSMC migration and matrix metalloproteinases. | Q51102422 | ||
Combining drug and gene similarity measures for drug-target elucidation. | Q51604037 | ||
Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke | Q57482501 | ||
Network pharmacology | Q57932497 | ||
Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Q63681992 | ||
From single drug targets to synergistic network pharmacology in ischemic stroke | Q64072607 | ||
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets | Q64081579 | ||
Microglia-derived TNF-α mediates endothelial necroptosis aggravating blood brain-barrier disruption after ischemic stroke. | Q64889137 | ||
Salidroside alleviates ischemic brain injury in mice with ischemic stroke through regulating BDNK mediated PI3K/Akt pathway | Q90980692 | ||
STRING: known and predicted protein-protein associations, integrated and transferred across organisms | Q24558597 | ||
DrugBank: a knowledgebase for drugs, drug actions and drug targets | Q24650300 | ||
Testosterone and the cardiovascular system: a comprehensive review of the basic science literature | Q26824556 | ||
Window of opportunity: estrogen as a treatment for ischemic stroke | Q26828794 | ||
Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date | Q27001147 | ||
DAVID: Database for Annotation, Visualization, and Integrated Discovery | Q27499374 | ||
Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. | Q27919665 | ||
The Kyoto Encyclopedia of Genes and Genomes—KEGG | Q28109327 | ||
Enhanced platelet activation by prolactin in patients with ischemic stroke | Q28198488 | ||
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants | Q28584435 | ||
The immunology of stroke: from mechanisms to translation | Q29620066 | ||
Cerebral ischemia induces transcription of inflammatory and extracellular-matrix-related genes in rat cerebral arteries | Q33298079 | ||
Pathologies associated with the p53 response | Q33931980 | ||
17β-estradiol and inflammation: implications for ischemic stroke | Q34237961 | ||
The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke. | Q34681421 | ||
The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease | Q34865360 | ||
Preclinical evaluation of recombinant T cell receptor ligand RTL1000 as a therapeutic agent in ischemic stroke | Q34982895 | ||
The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat | Q35225934 | ||
Akt as a mediator of cell death | Q36161549 | ||
Estrogens and experimental ischemic stroke: a systematic review | Q36377761 | ||
Transcription factors in airway diseases | Q36545751 | ||
BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine | Q36583396 | ||
Delayed intramuscular human neurotrophin-3 improves recovery in adult and elderly rats after stroke | Q36670885 | ||
High-dose estrogen treatment at reperfusion reduces lesion volume and accelerates recovery of sensorimotor function after experimental ischemic stroke. | Q36931700 | ||
T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation | Q36992998 | ||
PIKKing on PKB: regulation of PKB activity by phosphorylation | Q37419888 | ||
Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke. | Q37704935 | ||
Current perspective of pathophysiological and interventional effects on endothelial progenitor cell biology: focus on PI3K/AKT/eNOS pathway. | Q37742844 | ||
Epidemiology and the global burden of stroke | Q37969821 | ||
Characteristics of traditional Chinese medicine usage in patients with stroke in Taiwan: A nationwide population-based study. | Q38879628 | ||
Evidence that neuronal Notch-1 promotes JNK/c-Jun activation and cell death following ischemic stress. | Q38962027 | ||
Sex Hormones and Ischemic Stroke: A Prospective Cohort Study and Meta-Analyses | Q41175854 | ||
PRL as a novel potent cofactor for platelet aggregation | Q43819865 | ||
A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia | Q44560865 | ||
Traditional Chinese medicine and sports drug testing: identification of natural steroid administration in doping control urine samples resulting from musk (pod) extracts | Q44591484 | ||
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics | Q47116549 | ||
Searching Online Mendelian Inheritance in Man (OMIM): A Knowledgebase of Human Genes and Genetic Phenotypes | Q47786222 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P304 | page(s) | 4063180 | |
P577 | publication date | 2020-07-03 | |
P1433 | published in | Evidence-based Complementary and Alternative Medicine | Q5418319 |
P1476 | title | A Network Pharmacology Approach to Investigate the Active Compounds and Mechanisms of Musk for Ischemic Stroke | |
P478 | volume | 2020 |
Search more.